600
Participants
Start Date
November 26, 2017
Primary Completion Date
April 30, 2019
Study Completion Date
July 31, 2019
Mologic Biomarker Panel
In brief the proposed biomarkers will be measured in the laboratory of Mologic . These will initially be performed using standard lab assays (Enzyme Linked Immunosorbent Assays, ELISA). Biomarkers that show promise will then be mounted on a novel lateral flow device (under development), that could ultimately be deployed at the patients bedside.
RECRUITING
University College London Hospital, London
Lead Sponsor
Collaborators (1)
University College London Hospitals
OTHER
Innovate UK
OTHER_GOV
Mologic Ltd
INDUSTRY